Alzamend Neuro Inc. (NASDAQ:ALZN) has seen 1.33 million shares traded in the last trading session. The company, currently valued at $285.80M, closed the last trade at $3.13 per share which meant it lost -$0.22 on the day or -6.57% during that session. The ALZN stock price is -971.88% off its 52-week high price of $33.55 and 9.58% above the 52-week low of $2.83. The 3-month trading volume is 2.39 million shares.
Alzamend Neuro Inc. (NASDAQ:ALZN) trade information
Sporting -6.57% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the ALZN stock price touched $3.13 or saw a rise of 11.08%. Year-to-date, Alzamend Neuro Inc. shares have moved -76.81%, while the 5-day performance has seen it change 8.30%. Over the past 30 days, the shares of Alzamend Neuro Inc. (NASDAQ:ALZN) have changed -25.83%.
Alzamend Neuro Inc. (ALZN) estimates and forecasts
Alzamend Neuro Inc. is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Alzamend Neuro Inc. (NASDAQ:ALZN)’s Major holders
Insiders own 49.01% of the company shares, while shares held by institutions stand at 6.42% with a share float percentage of 12.60%. Investors are also buoyed by the number of investors in a company, with Alzamend Neuro Inc. having a total of 11 institutions that hold shares in the company. The top two institutional holders are Jane Street Group, LLC with over 0.13 million shares worth more than $1.17 million. As of Jun 29, 2021, Jane Street Group, LLC held 0.16% of shares outstanding.
The other major institutional holder is Susquehanna International Group, LLP, with the holding of over 57030.0 shares as of Jun 29, 2021. The firm’s total holdings are worth over $0.5 million and represent 0.07% of shares outstanding.